On air · 1 of 3 networks
The Pathologist ads
- thepathologist.com
- Internet Publishing
- GB
- 24 employees
The Pathologist’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 97. Watch The Pathologist on any plan to get each new one in your feed.
Watchlist included in every plan
What The Pathologist runs
- Single image · LinkedIn
- 4
- Video · LinkedIn
- 1
- Carousel · LinkedIn
- 1
- active Meta ad on 3 Nov 2026
- 1
- Meta placements
- 4
| Network | Status | Live ads | Nov 2025Activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 8 Nov 2026 | See all 97 ads → | ||
| Meta | Running | 1 | Checked 3 Nov 2026 | Collect them with the API → | |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 12 Oct 2026 | Collect them with the API → |
The Pathologist has no live LinkedIn ads. Its Facebook page had 1 active ad on 3 Nov 2026, and we recorded no Google ads on 12 Oct 2026.
Latest ads
- LINKEDIN · VIDEOSince 1 Nov 2026
Most workflow strain in anatomic pathology is hidden between steps: handoffs, queues, add-ons, changing priorities, and constant coordination. Work seems linear, but the reality is anything but. #Pathology #AnatomicPathology #Immunohistochemistry #Histology
- LINKEDIN · CAROUSELSince 30 Oct 2026
Connect with the Bio-Techne Diagnostics team 🤝 to discuss your laboratory needs and explore our expanding portfolio of molecular diagnostic kits. Learn More: https://lnkd.in/dVRBwUPs
- LINKEDIN · IMAGESince 28 Oct 2026
🔬 Looking to improve your confidence in PD-L1 CPS scoring? Join Agilent expert Karin Salomon for a case-based webinar exploring practical approaches to PD-L1 IHC 22C3 pharmDx Combined Positive Score (CPS) assessment. Discover how to: 🔹 Navigate challenging and borderline scoring cases 🔹 Identify and avoid common scoring pitfalls 🔹 Improve scoring consistency and reproducibility 🔹 Apply practical tips to your daily diagnostic workflow 📅 Wednesday, November 25, 2026 🕒 3:00 PM GMT Register now to strengthen your PD-L1 CPS scoring skills: https://lnkd.in/dX7EHeXF
- LINKEDIN · IMAGESince 27 Oct 2026
Could simpler access to AI accelerate its adoption in pathology? Complex procurement processes and infrastructure requirements can make it challenging for laboratories to integrate AI applications into diagnostic workflows. In this article, Elin Kindberg, Sectra's Global Product Manager for Digital Pathology, explores how Sectra Amplifier Services aims to simplify access to AI applications, reduce procurement barriers and streamline implementation. 🔗 Discover how this approach could help bring AI into routine pathology practice: https://lnkd.in/dAxDW9uB
- LINKEDIN · IMAGESince 23 Oct 2026
Bringing NGS in-house doesn’t have to mean added complexity. Hear practical insights from four experts on how an FDA-approved in vitro diagnostic workflow can help address common barriers to implementing NGS in the clinical lab. Explore regulatory verification, real-world implementation, integrated software, and reimbursement considerations. 👉 Read the report and explore a more streamlined approach to in-house NGS: https://lnkd.in/dcjRsKit
- LINKEDIN · IMAGESince 22 Oct 2026
🧬 Next-day comprehensive genomic profiling: How can laboratories make it happen? Join Dr. Elisa De Paolis as she shares Gemelli Hospital’s experience implementing a dual-track CGP approach using OCA Plus GX. Explore how optimized workflows, from sample preparation and sequencing to variant interpretation and tailored reporting, can support faster delivery of comprehensive genomic results. 📅 November 5 | 4 PM GMT | 5 PM CET | 11 AM EST 🔗 Register for the webinar: https://lnkd.in/dU7K2Sb8
6 of 97 adsSign up to see every The Pathologist ad, filter by format and date, and get alerts on new ones.
See all 97 adsOn Facebook and Instagram
Facebook page The Pathologist · 1 active ads, checked 3 Nov 2026 · 1 recorded
- All 1
- Image 1
META · IMAGESince 7 Oct 2026Active on Facebook, Instagram, Audience Network, Threads. Bring WGS-based MRD research into your lab. Illumina molecular residual disease (MRD) research ecosystem enables: • Broader tumor signal with whole genome sequencing (WGS) • High analytical sensitivity and specificity at low tumor fractions • Tumor informed, streamlined workflow in ≤5 days • Future ready flexibility Developed and supported by the global leader in sequencing technologies, Illumina delivers a fully connected platform to support performance, scalability, and evidence generation. Coming 2027. Now in early access for select translational research customers.
Questions about The Pathologist’s ads
Is The Pathologist running LinkedIn ads?
We recorded no live LinkedIn ads for The Pathologist on 10 Nov 2026.
How many LinkedIn ads has The Pathologist run?
LinkedIn’s ad library lists 87 ads for The Pathologist. We recorded 97 LinkedIn ads for The Pathologist, first recorded on 2 Oct 2026 and last recorded on 3 Nov 2026.
Does The Pathologist advertise on Facebook and Instagram?
Yes. The Pathologist’s Facebook page had 1 active ad in Meta’s Ad Library, last recorded on 3 Nov 2026.
Does The Pathologist run Google ads?
We recorded no Google ads for the domain thepathologist.com on 12 Oct 2026.
Which ad formats does The Pathologist use?
The 6 LinkedIn ads on this page include 4 image ads, 1 video ad and 1 carousel ad.
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.